AVAV

AeroVironment

$170.58

-7.14%
Jun 12, 2026
Bobby Quantitative Model
AeroVironment, Inc. is a defense technology company operating in the Aerospace & Defense industry, supplying unmanned aircraft systems (UAS), tactical missile systems, high-altitude pseudo-satellites, and related services primarily to the U.S. Department of Defense and allied international governments. The company is a recognized leader and technology provider in the unmanned systems and counter-UAS (drone defense) space, delivering integrated capabilities across air, land, sea, space, and cyber domains. The current investor narrative is dominated by extreme volatility driven by a mix of concrete government contract wins, a favorable political environment for domestic drone manufacturing, and significant negative catalysts including a major Q3 2026 earnings miss, a substantial goodwill impairment charge, and the termination of a critical $1.7 billion U.S. Space Force contract, creating a high-stakes debate between near-term operational setbacks and long-term strategic positioning.

People also watch

GE Aerospace

GE Aerospace

GE

Analysis
RTX

RTX

RTX

Analysis
Boeing

Boeing

BA

Analysis
Lockheed Martin

Lockheed Martin

LMT

Analysis
Howmet Aerospace

Howmet Aerospace

HWM

Analysis

BobbyInvestment Opinion: Should I buy AVAV Today?

Rating: Hold. The core thesis is that AVAV is a high-risk, high-potential turnaround story where severe near-term operational setbacks conflict with a compelling long-term strategic position, creating excessive volatility that currently warrants a sidelines stance.

Supporting evidence includes a valuation (PS ratio of 5.17x) near historical lows, suggesting limited multiple compression risk, but also reflecting deep fundamental issues. While revenue grew 143.4% YoY, profitability collapsed with a -38.4% net margin. The balance sheet is a key strength with a debt-to-equity of 0.073, but it is being eroded by negative FCF of -$195.3M. Analyst sentiment remains paradoxically bullish (9 out of 10 firms rate Buy/Outperform), indicating a belief in the long-term narrative despite the Q3 disaster.

The thesis would upgrade to a Buy if the company demonstrates a clear path to restoring gross margins above 30% and achieves positive quarterly free cash flow, signaling operational turnaround. It would downgrade to a Sell if quarterly revenue growth turns negative or if cash burn accelerates, threatening the balance sheet. Currently, the stock appears fairly valued relative to its own troubled history but remains overvalued if profitability does not recover, as the current PS multiple still implies growth expectations that are not being met.

Sign up to view all

AVAV 12-Month Price Forecast

The outlook is bifurcated and highly dependent on execution. The bull case is plausible given the strategic positioning and backlog, but the bear case is equally credible given the recent catastrophic operational performance. The base case of volatile, range-bound trading is most likely, as the company will need multiple quarters to rebuild credibility. The stance would upgrade to bullish on concrete evidence of margin recovery and positive cash flow, or downgrade to bearish on another major contract loss or accelerating cash burn.

Historical Price
Current Price $170.58
Average Target $220
High Target $390
Low Target $156

Wall Street consensus

Most Wall Street analysts maintain a constructive view on AeroVironment's 12-month outlook, with a consensus price target around $221.75 and implied upside of +30.0% versus the current price.

Average Target

$221.75

1 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

1

covering this stock

Price Range

$136 - $222

Analyst target range

Buy
0 (0%)
Hold
0 (0%)
Sell
1 (100%)

Insufficient analyst coverage data is available to form a meaningful consensus, as the provided data indicates only one analyst providing estimates. This limited coverage is typical for smaller mid-cap companies like AeroVironment (market cap ~$4.25B) and can lead to higher volatility and less efficient price discovery, as fewer institutional eyes are scrutinizing the business. The lack of a broad analyst target range makes it difficult to gauge Wall Street's conviction on the stock's fair value. The available institutional ratings data shows recent activity, with 9 out of 10 listed firms maintaining Buy or Outperform-equivalent ratings following the Q3 earnings report in March 2026, and only one downgrade from Underperform to Market Perform. This pattern suggests that despite the significant earnings miss and contract termination, a majority of covering analysts are maintaining a bullish long-term stance, likely based on the company's record backlog and positioning in counter-drone technology. However, the absence of quantified price targets and the small number of firms highlight the stock's niche coverage and the heightened uncertainty surrounding its near-term path.

Drowning in data?

Find the real signal!

Bulls vs Bears: AVAV Investment Factors

The evidence currently tilts bearish due to severe, concrete operational failures—namely the catastrophic Q3 earnings miss, gross margin collapse, and loss of a major contract—that outweigh the bullish narrative of strategic positioning and backlog. The most important tension in the investment debate is whether the company's strong balance sheet and leadership in counter-drone technology can successfully bridge the gap to profitability before its cash reserves are depleted by ongoing operational losses. The resolution of this cash burn versus growth trajectory dilemma will determine the stock's direction.

Bullish

  • Record Backlog & Strong Strategic Positioning: Despite a Q3 earnings miss, analysts maintain bullish long-term ratings (9 out of 10 firms rate Buy/Outperform) based on the company's record backlog and leadership in the high-growth counter-drone (C-UAS) market. This suggests institutional confidence in future contract conversion and revenue growth, supported by favorable political narratives around domestic drone manufacturing.
  • Robust Year-Over-Year Revenue Growth: The most recent quarterly revenue of $408.0 million represents a 143.4% year-over-year growth, indicating strong underlying demand for the company's defense technology products. This growth trajectory, while lumpy, demonstrates the company's ability to secure and execute on large government contracts.
  • Strong Balance Sheet with Minimal Debt: The company has a very low debt-to-equity ratio of 0.073 and a healthy current ratio of 3.52, providing significant financial flexibility and resilience. This strong liquidity position mitigates near-term solvency risk despite recent operational cash burn.
  • Valuation Near Historical Lows: The current Price-to-Sales (PS) ratio of 5.17x is near the lower end of its own historical range, which has seen figures as high as 33.27x. This suggests substantial pessimism may already be priced in, limiting further multiple contraction and offering a potential value entry point if fundamentals stabilize.

Bearish

  • Severe Profitability Collapse & Cash Burn: Q3 FY26 saw a net income of -$156.6 million and a net margin of -38.4%, driven partly by a major goodwill impairment. Gross margin collapsed to 17.1% from 38.0% in the prior year's Q4, and trailing twelve-month free cash flow is deeply negative at -$195.3 million, indicating unsustainable operational performance.
  • Critical $1.7B Space Force Contract Termination: The termination of a critical $1.7 billion U.S. Space Force contract represents a significant near-term revenue setback and raises serious questions about execution and program management capabilities. This loss is a direct contributor to the stock's 61.45% maximum drawdown and recent volatility.
  • Extreme Volatility & High Market Beta: The stock has a beta of 1.35, meaning it is 35% more volatile than the broader market, amplifying both gains and losses. This is evidenced by a 6-month decline of -26.6% and a 1-month surge of +22.6%, creating a high-risk environment for investors and complicating position sizing.
  • Lumpy Revenue & Poor Earnings Visibility: Quarterly revenue has shown extreme volatility, swinging from $275.1M to $472.5M and back to $408.0M, indicative of lumpy contract timing common in defense but adding significant execution and forecasting risk. The recent sequential decline from $472.5M also raises concerns about growth sustainability.

AVAV Technical Analysis

The prevailing price trend is a volatile downtrend within a broader consolidation, as evidenced by the 1-year price change of +11.4% masking a severe 6-month decline of -26.6%. The stock is currently trading at $204.4, which positions it at approximately 37% of its 52-week range ($156.0 to $417.86), indicating it is much closer to its annual lows than its highs, which typically suggests a value opportunity but also reflects significant fundamental deterioration and high investor uncertainty. Recent short-term momentum shows a sharp but potentially fragile rebound, with a 1-month price change of +22.6% significantly outperforming the S&P 500's +4.6%, yet this follows a steep 3-month decline of -11.1%. This divergence suggests the recent surge could be a technical bounce or short squeeze within a longer-term corrective phase, rather than a confirmed trend reversal, especially given the stock's high beta of 1.35, which implies it is 35% more volatile than the broader market, amplifying both gains and losses. Key technical levels are clearly defined, with immediate support at the recent 52-week low of $156.0 and major resistance at the 52-week high of $417.86. A sustained breakout above the recent high near $392.86 would signal a potential trend reversal and renewed bullish momentum, while a breakdown below the $156 support could trigger a new leg down in the downtrend. The stock's high beta of 1.35 confirms its status as a high-volatility name, which necessitates larger position sizing buffers for risk management, as its moves are magnified relative to the overall market, contributing to the dramatic 61.45% maximum drawdown observed in the provided data.

Beta

1.36

1.36x market volatility

Max Drawdown

-61.5%

Largest decline past year

52-Week Range

$156-$418

Price range past year

Annual Return

-10.3%

Cumulative gain past year

PeriodAVAV ReturnS&P 500
1m+6.0%-0.1%
3m-17.6%+12.0%
6m-28.6%+8.8%
1y-10.3%+22.9%
ytd-33.4%+8.8%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

AVAV Fundamental Analysis

Revenue trajectory shows significant quarterly volatility but underlying growth, with the most recent quarterly revenue at $408.0 million representing a robust 143.4% year-over-year growth. However, this figure is a sequential decline from the prior quarter's $472.5 million, and the multi-quarter trend reveals instability, with revenue swinging from $275.1 million (Q4 FY25) to $454.7 million (Q1 FY26) to $472.5 million (Q2 FY26) before the recent dip, indicating lumpy contract timing rather than smooth organic growth, which is common in the defense sector but adds execution risk. Profitability has severely deteriorated into deep losses, with the latest quarter posting a net income of -$156.6 million and a net margin of -38.4%, a stark contrast to the positive $16.7 million net income in the prior year's Q4. Gross margin collapsed to 17.1% in Q3 FY26 from 38.0% in Q4 FY25, indicating severe cost pressures or unfavorable contract mix, while operating margin turned negative at -5.1%. The company is currently unprofitable with losses widening significantly, driven in part by a substantial goodwill impairment charge, moving it sharply away from profitability and raising concerns about near-term earnings quality. The balance sheet shows a strong liquidity position with a current ratio of 3.52 and a very low debt-to-equity ratio of 0.073, indicating minimal financial leverage risk. However, cash flow generation is a critical weakness, with trailing twelve-month free cash flow deeply negative at -$195.3 million and operating cash flow for the latest quarter also negative at -$5.1 million. The negative ROA of -1.3% and a modest ROE of 4.9% reflect poor asset utilization and shareholder returns currently, suggesting the company is consuming cash to fund operations and is dependent on its strong balance sheet rather than internal cash generation, which is unsustainable long-term without a return to profitability.

Quarterly Revenue

$408045000.0B

2026-01

Revenue YoY Growth

+1.43%

YoY Comparison

Gross Margin

+0.17%

Latest Quarter

Free Cash Flow

$-195302000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Product and Service, Other

Open an Account, get $2 TSLA now!

Valuation Analysis: Is AVAV Overvalued?

Given the company's negative net income in the most recent quarter, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is 5.17x, while the forward-looking metric, EV-to-Sales, is 6.06x. The higher EV/Sales multiple suggests the market is anticipating some revenue growth or margin improvement, but the modest gap indicates tempered expectations following recent operational setbacks. Peer comparison is limited as specific industry average multiples are not provided in the data. However, the stock's valuation must be assessed in the context of its recent financial collapse. A PS ratio around 5x for a defense contractor with lumpy revenues, recent contract terminations, and deep losses could be considered elevated unless significant growth from its counter-drone and record backlog materializes. The premium or discount relative to peers would hinge on its perceived growth prospects versus its demonstrated execution risk. Historical context shows the current PS ratio of 5.17x is near the lower end of its own historical range observed in the data, which has seen figures as high as 33.27x (Q3 FY26) and as low as 13.91x (Q4 FY23). This suggests the market has already priced in substantial pessimism following the Q3 disaster, potentially limiting further multiple contraction. However, trading near historical lows can signify either a value opportunity if fundamentals stabilize or a warning of persistent deterioration if losses continue.

PE

97.3x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range -820x~33224x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

40.9x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks are severe and center on accelerating cash burn and collapsing profitability. The company reported a net loss of -$156.6M in Q3 FY26, with gross margins plummeting to 17.1% from 38.0% just two quarters prior. Trailing twelve-month free cash flow is deeply negative at -$195.3M, indicating the company is consuming its strong balance sheet to fund operations. This burn rate, coupled with lumpy revenue from large government contracts, creates high earnings volatility and raises sustainability concerns if profitability does not return swiftly.

Market & Competitive Risks are elevated due to the stock's high valuation premium and extreme volatility. Despite recent declines, the forward EV/Sales multiple of 6.06x suggests the market is still pricing in significant growth, which is at risk if execution stumbles further. The high beta of 1.35 means the stock is highly sensitive to broader market swings and sector rotations out of speculative growth names. Furthermore, the defense sector is becoming increasingly competitive, with new entrants like AEVEX raising capital via IPO, potentially threatening AVAV's market share in unmanned systems.

Worst-Case Scenario involves a continuation of operational missteps leading to further contract losses, sustained negative free cash flow, and a complete erosion of investor confidence. In this adverse scenario, the stock could re-test its 52-week low of $156.0, representing a downside of approximately -24% from the current price of $204.4. A breach of this key support could trigger a new leg down, potentially approaching levels implied by the stock's historical maximum drawdown of -61.45%, though the strong balance sheet provides a floor against total collapse.

FAQ

The key risks are, in order of severity: 1) Financial Risk: Accelerating cash burn, with trailing FCF at -$195.3M and gross margin collapse to 17.1%, threatening the balance sheet. 2) Operational/Execution Risk: Loss of a critical $1.7B contract raises doubts about program management, and revenue is notoriously lumpy. 3) Market Risk: The stock's high beta of 1.35 leads to extreme volatility, magnifying losses in downturns. 4) Competitive Risk: The defense drone sector is attracting new capital and competitors, potentially eroding AVAV's market leadership and pricing power over time.

The 12-month forecast is highly uncertain, with three distinct scenarios. The Base Case (50% probability) sees the stock trading between $190 and $250 as the company stabilizes but struggles with profitability. The Bull Case (25% probability) projects a rally to $330-$390 on successful backlog conversion, margin recovery, and new contract wins. The Bear Case (25% probability) warns of a decline to the $156-$180 range if operational deterioration continues. The most likely outcome is the Base Case, which assumes the company's strong balance sheet prevents a collapse but poor earnings visibility prevents a sustained rally.

AVAV's valuation is ambiguous and context-dependent. With a Price-to-Sales ratio of 5.17x, it is near the low end of its own historical range (which has exceeded 33x), suggesting it may be undervalued relative to its past. However, this lower multiple fully reflects recent catastrophic earnings and the Space Force contract termination. Given the company's deep losses and negative cash flow, the current multiple still implies the market expects a return to growth and profitability. Compared to a hypothetical profitable peer, AVAV would be overvalued, but as a distressed asset with a strong strategic narrative, it could be considered fairly valued for the high risk involved.

AVAV is a high-risk, high-potential stock that is not a good buy for most conservative investors. For aggressive investors comfortable with volatility, it may represent a speculative turnaround opportunity. The stock trades near historical valuation lows (PS 5.17x) and has a strong balance sheet (D/E 0.073), but these are offset by severe profitability issues (-$156.6M net income in Q3) and a major contract loss. It could be a good buy for those who believe the company's leadership in counter-drone tech will overcome near-term execution failures, but it requires a high risk tolerance and a long investment horizon.

AVAV is unsuitable for short-term trading for all but the most sophisticated traders due to its extreme volatility (beta 1.35) and low liquidity. It is theoretically a long-term investment for those betting on a multi-year defense technology cycle and a company-specific turnaround. However, given the severe near-term operational risks, any long-term position must be sized appropriately as a high-risk satellite holding. A minimum holding period of 2-3 years is suggested to allow time for the company to either prove its turnaround thesis or fail, as quarterly results will likely remain volatile and unpredictable.